Seattle Genetics

- NASDAQ:SGEN
Last Updated 2021-08-03
  • Seattle Genetics develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
  • Locations

    • Bothell WA
  • Industries

    Software, Mobile Apps, Real Estate, Cyber Security, Drones
  • Security

    Type: ORD
    CUSIP: 812578102
    ISIN: US8125781026
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.